We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
- Authors
Kovacs, Joseph A.; Lempicki, Richard A.; Sidorov, Igor A.; Adelsberger, Joseph W.; Sereti, Irini; Sachau, William; Kelly, Grace; Metcalf, Julia A.; Davey, Richard T.; Falloon, Judith; Polis, Michael A.; Tavel, Jorge; Stevens, Randy; Lambert, Laurie; Hosack, Douglas A.; Bosche, Marjorie; Issaq, Haleem J.; Fox, Stephen D.; Leitman, Susan; Baseler, Michael W.
- Abstract
HIV infection leads to decreases in the number of CD4 T lymphocytes and an increased risk for opportunistic infections and neoplasms. The administration of intermittent cycles of IL-2 to HIV-infected patients can lead to profound increases (often greater than 100%) in CD4 cell number and percentage. Using in vivo labeling with 2H-glucose and BrdU, we have been able to demonstrate that, although therapy with IL-2 leads to high levels of proliferation of CD4 as well as CD8 lymphocytes, it is a remarkable preferential increase in survival of CD4 cells (with half-lives that can exceed 3 years) that is critical to the sustained expansion of these cells. This increased survival was time-dependent: the median half-life, as determined by semiempirical modeling, of labeled CD4 cells in 6 patients increased from 1.7 weeks following an early IL-2 cycle to 28.7 weeks following a later cycle, while CD8 cells showed no change in the median half-life. Examination of lymphocyte subsets demonstrated that phenotypically naive (CD27+CD45RO-) as well as central memory (CD27+CD45RO+) CD4 cells were preferentially expanded, suggesting that IL-2 can help maintain cells important for host defense against new antigens as well as for long-term memory to opportunistic pathogens.
- Subjects
LYMPHOCYTES; LEUCOCYTES; HIV infections; HIV-positive persons; PATHOGENIC microorganisms; CD4 antigen; ANTIGENS; CELL physiology; COMPARATIVE studies; HIV; IMMUNITY; INTERLEUKIN-2; RESEARCH methodology; MEDICAL cooperation; OPPORTUNISTIC infections; RESEARCH; RESEARCH funding; T cells; EVALUATION research; ANTI-HIV agents
- Publication
Journal of Clinical Investigation, 2005, Vol 115, Issue 8, p2139
- ISSN
0021-9738
- Publication type
journal article
- DOI
10.1172/JCI23196